Nargiza Parpieva

Работ: 49

Tashkent Medical Academy , Tashkent, Uzbekistan

Detection of Nontuberculosis Mycobacteria in National Reference Laboratory (NRL) of Uzbekistan
Sanjar Sultanov, Nargiza Parpieva, Kazim Mukhamedov +3
СтатьяMycobacterium research and diagnosisTuberculosis2020Цитирований: 0
ABI
Adverse Drug Reactions among Children with Tuberculosis in Tashkent, Uzbekistan, 2019
Makhliyo Abdusalomova, Olga Denisiuk, Hayk Davtyan +4
СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 0
ABI
Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018
Zayniddin Sayfutdinov, Ajay Kumar, Dilyara Nabirova +5
СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 0
ABI
Incidence Rate and Risk Factors for Tuberculosis among People Living with HIV: A 2015–2017 Cohort from Tashkent, Uzbekistan
Dilbar Sadirova, Ruzanna Grigoryan, Nargiza Parpieva +9
СтатьяPneumocystis jirovecii pneumonia detection and treatmentInternational Journal of Environmental Research and Public Health2021Цитирований: 0
ABI
Characteristics and Treatment Outcomes of Patients with Tuberculosis Receiving Adjunctive Surgery in Uzbekistan
Anvar Riskiyev, Ana Ciobanu, Arax Hovhannesyan +3
СтатьяDiagnosis and treatment of tuberculosisInternational Journal of Environmental Research and Public Health2021Цитирований: 0
ABI
Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?
Laziz Turaev, Ajay Kumar, Dilyara Nabirova +3
СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 0
ABI
Adherence of drug-resistant tuberculosis patients to treatment in Tashkent, 2019-2020
Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +3
СтатьяTuberculosis Research and Epidemiology2021Цитирований: 0
ABI
Hospitalizations and Treatment Outcomes in Patients with Urogenital Tuberculosis in Tashkent, Uzbekistan, 2016–2018
Bakhtiyor Ismatov, Yuliia Sereda, S Sahakyan +2
СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 0
ABI
Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan
Horacio Gil, Hasmik Margaryan, I. Azamat +8
СтатьяTuberculosis Research and EpidemiologyTropical Medicine & International Health2021Цитирований: 0
ABI
Non-tuberculous mycobacteria in phthisiopulmonary practice in the Republic of Uzbekistan
Nargiza Parpieva, S Sultanov, M. Kh. Dzhurabaeva +1
СтатьяMycobacterium research and diagnosisTuberculosis and lung diseases2021Цитирований: 0
ABI
Treatment of multidrug-resistant tuberculosis in Uzbekistan from 2012 to 2018: does practice follow policy?
Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +8
СтатьяTuberculosis Research and Epidemiology2021Цитирований: 0
ABI
Is Xpert MTB/Rif Ultra superior to Xpert MTB/Rif for the diagnosis of tuberculosis in children in Uzbekistan
Sanjar Sultanov, Nargiza Parpieva, Kozim Mukhamedov +3
СтатьяIdeological and Political Education2021Цитирований: 0
ABI
Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan
Jamshid Gadoev, Anthony Harries, Oleksandr Korotych +7
Редакционная статьяDiverse Scientific Research StudiesInternational Journal of Environmental Research and Public Health2021Цитирований: 0
ABI
The impact of the COVID-19 pandemic on tuberculosis detection in Tashkent, Uzbekistan
Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +6
СтатьяDiverse Scientific Research Studies2023Цитирований: 0
ABI
Introducing BPaL: Experiences from countries supported under the LIFT-TB project
D. F. Wares, M. Mbenga, Veriko Mirtskhulava +19
СтатьяTuberculosis Research and EpidemiologyPLoS ONE2024Цитирований: 0
ABI
How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial
Ilaria Motta, Martina Cusinato, Andrew Ludman +15
СтатьяCardiac electrophysiology and arrhythmiasAntimicrobial Agents and Chemotherapy2024Цитирований: 0
ABI
Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan
S. Moe, I. Azamat, Sholpan Allamuratova +14
СтатьяTuberculosis Research and EpidemiologyIJTLD OPEN2024Цитирований: 0
ABI
Study the Occurrence of Mycobacterium Bovis in Tuberculosis of Peripheral Lymph Nodes and its Effect on the Course of the Disease.
Nargiza Parpieva, Askar Anvarovich Adilkhodzhaev, Zarifa Abdiraubovna Muminova
СтатьяTuberculosis Research and EpidemiologyBiomedical & Pharmacology Journal2024Цитирований: 0
ABI
Features of colposcopy in patients with various forms of pulmonary tuberculosis
Marufdjon Yuldashev, Nargiza Parpieva, Shaxnoza Zufarova
СтатьяDiagnosis and treatment of tuberculosis2024Цитирований: 0
ABI
The effectiveness of pulmonary tuberculosis treatment during the COVID-19 pandemic
Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko +6
СтатьяCOVID-19 Prevention and Impact2024Цитирований: 0
ABI
A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020
Michael L. Rekart, Phone Thit, Modupe Oluya +14
Обзорная статьяTuberculosis Research and EpidemiologyIJTLD OPEN2024Цитирований: 0
ABI
The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan
Animesh A. Sinha, Robert J. Klebe, Michael L. Rekart +22
СтатьяTuberculosis Research and EpidemiologyClinical Infectious Diseases2025Цитирований: 0
ABI
Evaluation of TB treatment outcomes in outpatient settings during the COVID-19 pandemic
Ruzilya Usmanova, Nargiza Parpieva, Irina Liverko
СтатьяTuberculosis Research and Epidemiology2025Цитирований: 0
ABI
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis
Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97
Обзорная статьяTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health2025Цитирований: 0
ABI